Literature DB >> 33654889

Immunohistochemical Staining of TLR4 in Human Skeletal Muscle Samples.

Daniela Verzola1, Samantha Milanesi1, Francesca Costigliolo1, Giacomo Garibotto1.   

Abstract

Growing evidence suggests the involvement of TLR4, a receptor in the innate immune system, in muscle loss in uremia. Recently, we have evaluated TLR4 in human skeletal muscle from chronic kidney disease patients, by immunohistochemistry and image analysis. Unlike the commonly-used Western blot method, immunohistochemistry allows for the observation of protein distribution in the intact tissue while, image analysis, its quantification. In fact, our data highlighted our hypothesis that an enhanced TLR4 skeletal muscle cell expression contributes to the activation of the downward inflammatory pathway in uremic sarcopenia. In this protocol, we describe the procedure for immunostaining TLR4 in human skeletal muscle and for quantifying it by image analysis.
Copyright © 2019 The Authors; exclusive licensee Bio-protocol LLC.

Entities:  

Keywords:  Antigen unmasking; CDK; Human skeletal muscle; Image analysis; Immunohistochemistry; Paraffin-embedded muscle; Quantification; TLR4

Year:  2019        PMID: 33654889      PMCID: PMC7854053          DOI: 10.21769/BioProtoc.3144

Source DB:  PubMed          Journal:  Bio Protoc        ISSN: 2331-8325


  10 in total

Review 1.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 2.  The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors.

Authors:  Taro Kawai; Shizuo Akira
Journal:  Nat Immunol       Date:  2010-04-20       Impact factor: 25.606

Review 3.  Inflammation and Protein-Energy Wasting in the Uremic Milieu.

Authors:  Magdalena Jankowska; Gabriela Cobo; Bengt Lindholm; Peter Stenvinkel
Journal:  Contrib Nephrol       Date:  2017-09-14       Impact factor: 1.580

Review 4.  High-mobility group box 1 protein (HMGB1) operates as an alarmin outside as well as inside cells.

Authors:  Ulf Andersson; Huan Yang; Helena Harris
Journal:  Semin Immunol       Date:  2018-03-09       Impact factor: 11.130

Review 5.  Regulation of innate immune responses by Toll-like receptors.

Authors:  K Takeda; S Akira
Journal:  Jpn J Infect Dis       Date:  2001-12       Impact factor: 1.362

6.  Salivary mucins induce a Toll-like receptor 4-mediated pro-inflammatory response in human submandibular salivary cells: are mucins involved in Sjögren's syndrome?

Authors:  María-José Barrera; Sergio Aguilera; Enno Veerman; Andrew F G Quest; David Díaz-Jiménez; Ulises Urzúa; Juan Cortés; Sergio González; Isabel Castro; Claudio Molina; Verónica Bahamondes; Cecilia Leyton; Marcela A Hermoso; María-Julieta González
Journal:  Rheumatology (Oxford)       Date:  2015-03-22       Impact factor: 7.580

Review 7.  Differential activation of Toll-like receptor-mediated apoptosis induced by hypoxia.

Authors:  Sanae Ben Mkaddem; Marcelle Bens; Alain Vandewalle
Journal:  Oncotarget       Date:  2010-12

8.  TLR4 Expression Is Associated with Left Ventricular Dysfunction in Patients Undergoing Coronary Artery Bypass Surgery.

Authors:  Orna Avlas; Arieh Bragg; Avi Fuks; James D Nicholson; Ariel Farkash; Eyal Porat; Dan Aravot; Rachel S Levy-Drummer; Cyrille Cohen; Asher Shainberg; Michael Arad; Edith Hochhauser
Journal:  PLoS One       Date:  2015-06-01       Impact factor: 3.240

9.  Toll-like receptor 4 mediates Lewis lung carcinoma-induced muscle wasting via coordinate activation of protein degradation pathways.

Authors:  Guohua Zhang; Zhelong Liu; Hui Ding; Hongyu Miao; Jose M Garcia; Yi-Ping Li
Journal:  Sci Rep       Date:  2017-05-23       Impact factor: 4.379

10.  Toll-like receptor 4 signalling mediates inflammation in skeletal muscle of patients with chronic kidney disease.

Authors:  Daniela Verzola; Alice Bonanni; Antonella Sofia; Fabrizio Montecucco; Elena D'Amato; Valeria Cademartori; Emanuele Luigi Parodi; Francesca Viazzi; Chiara Venturelli; Giuliano Brunori; Giacomo Garibotto
Journal:  J Cachexia Sarcopenia Muscle       Date:  2016-10-18       Impact factor: 12.910

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.